Evidence map›Paper›PMID 26019576›Full record

ArticleBiotechnology, biotechnological equipment2014

Investigation of the role of

Tatyana Vlaykova, Mateusz Kurzawski, Tanya Tacheva, Dimo Dimov, Maya Gulubova, Yovcho Yovchev, Stoyan Chakarov, Marek Drozdzik

Open access · goldAbstract read
In one paragraph

Article in Biotechnology, biotechnological equipment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis.International journal of molecular sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tatyana VlaykovaDepartment of Chemistry and Biochemistry, Medical Faculty, Trakia Univesity , Stara Zagora , Bulgaria.
Mateusz KurzawskiDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University , Szczecin , Poland.
Tanya TachevaDepartment of Chemistry and Biochemistry, Medical Faculty, Trakia Univesity , Stara Zagora , Bulgaria.
Dimo DimovDepartment of Internal Medicine, Medical Faculty, Trakia Univesity , Stara Zagora , Bulgaria.
Maya GulubovaDepartment of General and Clinical Pathology, Medical Faculty, Trakia Univesity , Stara Zagora , Bulgaria.
Yovcho YovchevDepartment of General Surgery, Medical Faculty, Trakia Univesity , Stara Zagora , Bulgaria.
Stoyan ChakarovDepartment of Biochemistry, Faculty of Biology, Sofia University , Sofia , Bulgaria.
Marek DrozdzikDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University , Szczecin , Poland.
Trakia University · BGSofia University "St. Kliment Ohridski" · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coetaneous malignant melanoma is the most aggressive cancer of the skin with a high rate of mortality worldwide. Degradation of basement membranes and extracellular matrix is an essential step in cancer invasion and metastasis. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play key roles in this step. MMP-3 also called stromelysin-1 was one of the first proteinases found to be associated with cancer. In the gene of MMP-3

Indexed as

genetic predispositionMMP3skin malignant melanomasurvival

Identifiers

PMID26019576
PMCPMC4434098
OpenAlexW2035381167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.